Strong China demand for bone, joint supplement drives Caltrate to double-digit growth in Q1 By Tingmin Koe 05-Jun-2024 - Last updated on 05-Jun-2024 at 05:57 GMT Facebook Twitter Linkedin Email to a friend Caltrate, the bone and joint health supplement brand from Haleon, has reported double-digit revenue growth in Q1 largely due to strong demand from China.Read the full story here. NIA top stories monthly Nestle taps into Dr. Reddy’s nutra distribution network to boost India reach Big bang: Pill-and-shot supplements trending in South Korea with major brands jumping on the bandwagon “Hidden talents”: Malaysia’s biopharma firm sees vast R&D opportunities in over 3,000 local medicinal plants Indian regulator clamps down on e-commerce sites selling “health drinks” Taiwan nutra market: Eye health, beauty, probiotics trending, with food firms, influencers entering business Strong China demand for bone, joint supplement drives Caltrate to double-digit growth in Q1 Swisse’s owner H&H Group reports double-digit growth in China’s adult nutrition market Urgent action needed: NZ natural products industry demands action to boost exports as Therapeutic Products Act repealed Core brand approach: Thailand boost brings Suntory’s health supplement business back to growth Bringing into focus: Japan’s natural tech releases new eye supplement amid ‘skyrocketing demand’ Prev 1 … 5 6 7 8 9 … 11 Next
